<!DOCTYPE html><html><head><title> Pacifica Code Section 58-37-S4 </title><link rel="stylesheet" href="../../assets/style.css"/></head><body>
<b><i>
                      Effective 5/4/2022</i></b>
<br>
<b>58-37-4.&nbsp;
          </b><b>Schedules of controlled substances -- Schedules I through V -- Findings required -- Specific substances included in schedules.</b>
<br>
<a id="58-37-4(1)" name="58-37-4(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
There are established five schedules of controlled substances known as Schedules I, II, III, IV, and V which consist of substances listed in this section.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)" name="58-37-4(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
Schedules I, II, III, IV, and V consist of the following drugs or other substances by the official name, common or usual name, chemical name, or brand name designated:
<a id="58-37-4(2)(a)" name="58-37-4(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
Schedule I:<a id="58-37-4(2)(a)(i)" name="58-37-4(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation:
<a id="58-37-4(2)(a)(i)(A)" name="58-37-4(2)(a)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(B)" name="58-37-4(2)(a)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Acetyl fentanyl:  (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(C)" name="58-37-4(2)(a)(i)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Acetylmethadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(D)" name="58-37-4(2)(a)(i)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(E)" name="58-37-4(2)(a)(i)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Allylprodine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(F)" name="58-37-4(2)(a)(i)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Alphacetylmethadol, except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(G)" name="58-37-4(2)(a)(i)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Alphameprodine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(H)" name="58-37-4(2)(a)(i)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Alphamethadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(I)" name="58-37-4(2)(a)(i)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(J)" name="58-37-4(2)(a)(i)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(K)" name="58-37-4(2)(a)(i)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Benzylpiperazine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(L)" name="58-37-4(2)(a)(i)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
Benzethidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(M)" name="58-37-4(2)(a)(i)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
Betacetylmethadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(N)" name="58-37-4(2)(a)(i)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(O)" name="58-37-4(2)(a)(i)(O)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(O)</td><td style="width:99%">
Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(P)" name="58-37-4(2)(a)(i)(P)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(P)</td><td style="width:99%">
Betameprodine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(Q)" name="58-37-4(2)(a)(i)(Q)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Q)</td><td style="width:99%">
Betamethadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(R)" name="58-37-4(2)(a)(i)(R)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(R)</td><td style="width:99%">
Betaprodine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(S)" name="58-37-4(2)(a)(i)(S)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(S)</td><td style="width:99%">
Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(T)" name="58-37-4(2)(a)(i)(T)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(T)</td><td style="width:99%">
Clonitazene;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(U)" name="58-37-4(2)(a)(i)(U)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(U)</td><td style="width:99%">
Cyclopropyl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(V)" name="58-37-4(2)(a)(i)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Dextromoramide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(W)" name="58-37-4(2)(a)(i)(W)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(W)</td><td style="width:99%">
Diampromide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(X)" name="58-37-4(2)(a)(i)(X)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(X)</td><td style="width:99%">
Diethylthiambutene;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(Y)" name="58-37-4(2)(a)(i)(Y)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Y)</td><td style="width:99%">
Difenoxin;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(Z)" name="58-37-4(2)(a)(i)(Z)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Z)</td><td style="width:99%">
Dimenoxadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(AA)" name="58-37-4(2)(a)(i)(AA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AA)</td><td style="width:99%">
Dimepheptanol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(BB)" name="58-37-4(2)(a)(i)(BB)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(BB)</td><td style="width:99%">
Dimethylthiambutene;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(CC)" name="58-37-4(2)(a)(i)(CC)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(CC)</td><td style="width:99%">
Dioxaphetyl butyrate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(DD)" name="58-37-4(2)(a)(i)(DD)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(DD)</td><td style="width:99%">
Dipipanone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(EE)" name="58-37-4(2)(a)(i)(EE)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(EE)</td><td style="width:99%">
Ethylmethylthiambutene;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(FF)" name="58-37-4(2)(a)(i)(FF)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(FF)</td><td style="width:99%">
Etizolam  (1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(GG)" name="58-37-4(2)(a)(i)(GG)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(GG)</td><td style="width:99%">
Etonitazene;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(HH)" name="58-37-4(2)(a)(i)(HH)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(HH)</td><td style="width:99%">
Etoxeridine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(II)" name="58-37-4(2)(a)(i)(II)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(II)</td><td style="width:99%">
Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] furan-2-carboxamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(JJ)" name="58-37-4(2)(a)(i)(JJ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(JJ)</td><td style="width:99%">
Furethidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(KK)" name="58-37-4(2)(a)(i)(KK)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(KK)</td><td style="width:99%">
Hydroxypethidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(LL)" name="58-37-4(2)(a)(i)(LL)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(LL)</td><td style="width:99%">
Ketobemidone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(MM)" name="58-37-4(2)(a)(i)(MM)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(MM)</td><td style="width:99%">
Levomoramide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(NN)" name="58-37-4(2)(a)(i)(NN)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(NN)</td><td style="width:99%">
Levophenacylmorphan;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(OO)" name="58-37-4(2)(a)(i)(OO)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(OO)</td><td style="width:99%">
Methoxyacetyl fentanyl (2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(PP)" name="58-37-4(2)(a)(i)(PP)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(PP)</td><td style="width:99%">
Morpheridine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(QQ)" name="58-37-4(2)(a)(i)(QQ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(QQ)</td><td style="width:99%">
MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(RR)" name="58-37-4(2)(a)(i)(RR)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(RR)</td><td style="width:99%">
Noracymethadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(SS)" name="58-37-4(2)(a)(i)(SS)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(SS)</td><td style="width:99%">
Norlevorphanol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(TT)" name="58-37-4(2)(a)(i)(TT)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(TT)</td><td style="width:99%">
Normethadone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(UU)" name="58-37-4(2)(a)(i)(UU)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(UU)</td><td style="width:99%">
Norpipanone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(VV)" name="58-37-4(2)(a)(i)(VV)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(VV)</td><td style="width:99%">
Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl] propanamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(WW)" name="58-37-4(2)(a)(i)(WW)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(WW)</td><td style="width:99%">
Para-fluoroisobutyryl fentanyl (N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(XX)" name="58-37-4(2)(a)(i)(XX)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XX)</td><td style="width:99%">
PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(YY)" name="58-37-4(2)(a)(i)(YY)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(YY)</td><td style="width:99%">
Phenadoxone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(ZZ)" name="58-37-4(2)(a)(i)(ZZ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ZZ)</td><td style="width:99%">
Phenampromide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(AAA)" name="58-37-4(2)(a)(i)(AAA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AAA)</td><td style="width:99%">
Phenomorphan;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(BBB)" name="58-37-4(2)(a)(i)(BBB)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(BBB)</td><td style="width:99%">
Phenoperidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(CCC)" name="58-37-4(2)(a)(i)(CCC)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(CCC)</td><td style="width:99%">
Piritramide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(DDD)" name="58-37-4(2)(a)(i)(DDD)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(DDD)</td><td style="width:99%">
Proheptazine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(EEE)" name="58-37-4(2)(a)(i)(EEE)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(EEE)</td><td style="width:99%">
Properidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(FFF)" name="58-37-4(2)(a)(i)(FFF)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(FFF)</td><td style="width:99%">
Propiram;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(GGG)" name="58-37-4(2)(a)(i)(GGG)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(GGG)</td><td style="width:99%">
Racemoramide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(HHH)" name="58-37-4(2)(a)(i)(HHH)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(HHH)</td><td style="width:99%">
Tetrahydrofuran fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(III)" name="58-37-4(2)(a)(i)(III)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(III)</td><td style="width:99%">
Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(JJJ)" name="58-37-4(2)(a)(i)(JJJ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(JJJ)</td><td style="width:99%">
Tilidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(KKK)" name="58-37-4(2)(a)(i)(KKK)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(KKK)</td><td style="width:99%">
Trimeperidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(LLL)" name="58-37-4(2)(a)(i)(LLL)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(LLL)</td><td style="width:99%">
3-methylfentanyl, including the optical and geometric isomers (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(MMM)" name="58-37-4(2)(a)(i)(MMM)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(MMM)</td><td style="width:99%">
3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(NNN)" name="58-37-4(2)(a)(i)(NNN)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(NNN)</td><td style="width:99%">
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also known as U-47700; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(i)(OOO)" name="58-37-4(2)(a)(i)(OOO)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(OOO)</td><td style="width:99%">
4-cyano CUMYL-BUTINACA.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)" name="58-37-4(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
<a id="58-37-4(2)(a)(ii)(A)" name="58-37-4(2)(a)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Acetorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(B)" name="58-37-4(2)(a)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Acetyldihydrocodeine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(C)" name="58-37-4(2)(a)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Benzylmorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(D)" name="58-37-4(2)(a)(ii)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Codeine methylbromide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(E)" name="58-37-4(2)(a)(ii)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Codeine-N-Oxide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(F)" name="58-37-4(2)(a)(ii)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Cyprenorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(G)" name="58-37-4(2)(a)(ii)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Desomorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(H)" name="58-37-4(2)(a)(ii)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Dihydromorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(I)" name="58-37-4(2)(a)(ii)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Drotebanol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(J)" name="58-37-4(2)(a)(ii)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Etorphine (except hydrochloride salt);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(K)" name="58-37-4(2)(a)(ii)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Heroin;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(L)" name="58-37-4(2)(a)(ii)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
Hydromorphinol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(M)" name="58-37-4(2)(a)(ii)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
Methyldesorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(N)" name="58-37-4(2)(a)(ii)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Methylhydromorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(O)" name="58-37-4(2)(a)(ii)(O)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(O)</td><td style="width:99%">
Morphine methylbromide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(P)" name="58-37-4(2)(a)(ii)(P)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(P)</td><td style="width:99%">
Morphine methylsulfonate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(Q)" name="58-37-4(2)(a)(ii)(Q)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Q)</td><td style="width:99%">
Morphine-N-Oxide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(R)" name="58-37-4(2)(a)(ii)(R)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(R)</td><td style="width:99%">
Myrophine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(S)" name="58-37-4(2)(a)(ii)(S)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(S)</td><td style="width:99%">
Nicocodeine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(T)" name="58-37-4(2)(a)(ii)(T)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(T)</td><td style="width:99%">
Nicomorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(U)" name="58-37-4(2)(a)(ii)(U)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(U)</td><td style="width:99%">
Normorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(V)" name="58-37-4(2)(a)(ii)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Pholcodine; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(ii)(W)" name="58-37-4(2)(a)(ii)(W)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(W)</td><td style="width:99%">
Thebacon.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)" name="58-37-4(2)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of their salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation; as used in this Subsection <a href="#58-37-4(2)(a)(iii)">(2)(a)(iii)</a> only, "isomer" includes the optical, position, and geometric isomers:
<a id="58-37-4(2)(a)(iii)(A)" name="58-37-4(2)(a)(iii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(B)" name="58-37-4(2)(a)(iii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
4-bromo-2,5-dimethoxy-amphetamine, some trade or other names: 4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(C)" name="58-37-4(2)(a)(iii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
4-bromo-2,5-dimethoxyphenethylamine, some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(D)" name="58-37-4(2)(a)(iii)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
2,5-dimethoxyamphetamine, some trade or other names: 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(E)" name="58-37-4(2)(a)(iii)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(F)" name="58-37-4(2)(a)(iii)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
4-methoxyamphetamine, some trade or other names: 4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(G)" name="58-37-4(2)(a)(iii)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
5-methoxy-3,4-methylenedioxyamphetamine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(H)" name="58-37-4(2)(a)(iii)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
4-methyl-2,5-dimethoxy-amphetamine, some trade and other names: 4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(I)" name="58-37-4(2)(a)(iii)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
3,4-methylenedioxy amphetamine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(J)" name="58-37-4(2)(a)(iii)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
3,4-methylenedioxymethamphetamine (MDMA);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(K)" name="58-37-4(2)(a)(iii)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl- alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(L)" name="58-37-4(2)(a)(iii)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
N-hydroxy-3,4-methylenedioxyamphetamine, also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(M)" name="58-37-4(2)(a)(iii)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
3,4,5-trimethoxy amphetamine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(N)" name="58-37-4(2)(a)(iii)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Bufotenine, some trade and other names: 3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(O)" name="58-37-4(2)(a)(iii)(O)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(O)</td><td style="width:99%">
Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(P)" name="58-37-4(2)(a)(iii)(P)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(P)</td><td style="width:99%">
Dimethyltryptamine, some trade or other names: DMT;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(Q)" name="58-37-4(2)(a)(iii)(Q)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Q)</td><td style="width:99%">
Ibogaine, some trade and other names: 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino [5,4-b] indole; Tabernanthe iboga;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(R)" name="58-37-4(2)(a)(iii)(R)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(R)</td><td style="width:99%">
Lysergic acid diethylamide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(S)" name="58-37-4(2)(a)(iii)(S)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(S)</td><td style="width:99%">
Marijuana;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(T)" name="58-37-4(2)(a)(iii)(T)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(T)</td><td style="width:99%">
Mescaline;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(U)" name="58-37-4(2)(a)(iii)(U)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(U)</td><td style="width:99%">
Parahexyl, some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(V)" name="58-37-4(2)(a)(iii)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Peyote, meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(W)" name="58-37-4(2)(a)(iii)(W)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(W)</td><td style="width:99%">
N-ethyl-3-piperidyl benzilate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(X)" name="58-37-4(2)(a)(iii)(X)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(X)</td><td style="width:99%">
N-methyl-3-piperidyl benzilate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(Y)" name="58-37-4(2)(a)(iii)(Y)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Y)</td><td style="width:99%">
Psilocybin;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(Z)" name="58-37-4(2)(a)(iii)(Z)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Z)</td><td style="width:99%">
Psilocyn;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(AA)" name="58-37-4(2)(a)(iii)(AA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AA)</td><td style="width:99%">
Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis (cannabis plant), except for marijuana as defined in Subsection <a href="../../Title58/Chapter37/58-37-S2.html?v=C58-37-S2_2022050420220504#58-37-2(1)(aa)(i)(E)">58-37-2(1)(aa)(i)(E)</a>, as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6 cis or trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(BB)" name="58-37-4(2)(a)(iii)(BB)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(BB)</td><td style="width:99%">
Ethylamine analog of phencyclidine, some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(CC)" name="58-37-4(2)(a)(iii)(CC)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(CC)</td><td style="width:99%">
Pyrrolidine analog of phencyclidine, some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(DD)" name="58-37-4(2)(a)(iii)(DD)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(DD)</td><td style="width:99%">
Thiophene analog of phencyclidine, some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iii)(EE)" name="58-37-4(2)(a)(iii)(EE)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(EE)</td><td style="width:99%">
1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iv)" name="58-37-4(2)(a)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
<a id="58-37-4(2)(a)(iv)(A)" name="58-37-4(2)(a)(iv)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Mecloqualone; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(iv)(B)" name="58-37-4(2)(a)(iv)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Methaqualone.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)" name="58-37-4(2)(a)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
Any material, compound, mixture, or preparation containing any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers:
<a id="58-37-4(2)(a)(v)(A)" name="58-37-4(2)(a)(v)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)(B)" name="58-37-4(2)(a)(v)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)(C)" name="58-37-4(2)(a)(v)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Fenethylline;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)(D)" name="58-37-4(2)(a)(v)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Methcathinone, some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of optical isomers;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)(E)" name="58-37-4(2)(a)(v)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
(±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)(F)" name="58-37-4(2)(a)(v)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
N-ethylamphetamine; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(v)(G)" name="58-37-4(2)(a)(v)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
N,N-dimethylamphetamine, also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(vi)" name="58-37-4(2)(a)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
Any material, compound, mixture, or preparation which contains any quantity of the following substances, including their optical isomers, salts, and salts of isomers, subject to temporary emergency scheduling:
<a id="58-37-4(2)(a)(vi)(A)" name="58-37-4(2)(a)(vi)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(vi)(B)" name="58-37-4(2)(a)(vi)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(a)(vii)" name="58-37-4(2)(a)(vii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)" name="58-37-4(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
Schedule II:<a id="58-37-4(2)(b)(i)" name="58-37-4(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
<a id="58-37-4(2)(b)(i)(A)" name="58-37-4(2)(b)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including:<a id="58-37-4(2)(b)(i)(A)(I)" name="58-37-4(2)(b)(i)(A)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Raw opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(II)" name="58-37-4(2)(b)(i)(A)(II)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(II)</td><td style="width:99%">
Opium extracts;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(III)" name="58-37-4(2)(b)(i)(A)(III)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(III)</td><td style="width:99%">
Opium fluid;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(IV)" name="58-37-4(2)(b)(i)(A)(IV)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(IV)</td><td style="width:99%">
Powdered opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(V)" name="58-37-4(2)(b)(i)(A)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Granulated opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(VI)" name="58-37-4(2)(b)(i)(A)(VI)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(VI)</td><td style="width:99%">
Tincture of opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(VII)" name="58-37-4(2)(b)(i)(A)(VII)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(VII)</td><td style="width:99%">
Codeine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(VIII)" name="58-37-4(2)(b)(i)(A)(VIII)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(VIII)</td><td style="width:99%">
Ethylmorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(IX)" name="58-37-4(2)(b)(i)(A)(IX)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(IX)</td><td style="width:99%">
Etorphine hydrochloride;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(X)" name="58-37-4(2)(b)(i)(A)(X)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(X)</td><td style="width:99%">
Hydrocodone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(XI)" name="58-37-4(2)(b)(i)(A)(XI)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XI)</td><td style="width:99%">
Hydromorphone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(XII)" name="58-37-4(2)(b)(i)(A)(XII)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XII)</td><td style="width:99%">
Metopon;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(XIII)" name="58-37-4(2)(b)(i)(A)(XIII)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XIII)</td><td style="width:99%">
Morphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(XIV)" name="58-37-4(2)(b)(i)(A)(XIV)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XIV)</td><td style="width:99%">
Oxycodone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(XV)" name="58-37-4(2)(b)(i)(A)(XV)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XV)</td><td style="width:99%">
Oxymorphone; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(A)(XVI)" name="58-37-4(2)(b)(i)(A)(XVI)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XVI)</td><td style="width:99%">
Thebaine;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(B)" name="58-37-4(2)(b)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Any salt, compound, derivative, or preparation which is chemically equivalent or identical with any of the substances referred to in Subsection <a href="#58-37-4(2)(b)(i)(A)">(2)(b)(i)(A)</a>, except that these substances may not include the isoquinoline alkaloids of opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(C)" name="58-37-4(2)(b)(i)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Opium poppy and poppy straw;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(D)" name="58-37-4(2)(b)(i)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation which is chemically equivalent or identical with any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives, and salts of isomers and derivatives, whether derived from the coca plant or synthetically produced, except the substances may not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(i)(E)" name="58-37-4(2)(b)(i)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Concentrate of poppy straw, which means the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)" name="58-37-4(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation, except dextrorphan and levopropoxyphene:
<a id="58-37-4(2)(b)(ii)(A)" name="58-37-4(2)(b)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Alfentanil;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(B)" name="58-37-4(2)(b)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Alphaprodine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(C)" name="58-37-4(2)(b)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Anileridine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(D)" name="58-37-4(2)(b)(ii)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Bezitramide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(E)" name="58-37-4(2)(b)(ii)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Bulk dextropropoxyphene (nondosage forms);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(F)" name="58-37-4(2)(b)(ii)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Carfentanil;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(G)" name="58-37-4(2)(b)(ii)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Dihydrocodeine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(H)" name="58-37-4(2)(b)(ii)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Diphenoxylate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(I)" name="58-37-4(2)(b)(ii)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Fentanyl;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(J)" name="58-37-4(2)(b)(ii)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Isomethadone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(K)" name="58-37-4(2)(b)(ii)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(L)" name="58-37-4(2)(b)(ii)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
Levomethorphan;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(M)" name="58-37-4(2)(b)(ii)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
Levorphanol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(N)" name="58-37-4(2)(b)(ii)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Metazocine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(O)" name="58-37-4(2)(b)(ii)(O)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(O)</td><td style="width:99%">
Methadone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(P)" name="58-37-4(2)(b)(ii)(P)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(P)</td><td style="width:99%">
Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(Q)" name="58-37-4(2)(b)(ii)(Q)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Q)</td><td style="width:99%">
Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(R)" name="58-37-4(2)(b)(ii)(R)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(R)</td><td style="width:99%">
Pethidine (meperidine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(S)" name="58-37-4(2)(b)(ii)(S)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(S)</td><td style="width:99%">
Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(T)" name="58-37-4(2)(b)(ii)(T)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(T)</td><td style="width:99%">
Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(U)" name="58-37-4(2)(b)(ii)(U)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(U)</td><td style="width:99%">
Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(V)" name="58-37-4(2)(b)(ii)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Phenazocine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(W)" name="58-37-4(2)(b)(ii)(W)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(W)</td><td style="width:99%">
Piminodine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(X)" name="58-37-4(2)(b)(ii)(X)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(X)</td><td style="width:99%">
Racemethorphan;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(Y)" name="58-37-4(2)(b)(ii)(Y)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Y)</td><td style="width:99%">
Racemorphan;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(Z)" name="58-37-4(2)(b)(ii)(Z)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Z)</td><td style="width:99%">
Remifentanil; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(ii)(AA)" name="58-37-4(2)(b)(ii)(AA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AA)</td><td style="width:99%">
Sufentanil.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iii)" name="58-37-4(2)(b)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
<a id="58-37-4(2)(b)(iii)(A)" name="58-37-4(2)(b)(iii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Amphetamine, its salts, optical isomers, and salts of its optical isomers;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iii)(B)" name="58-37-4(2)(b)(iii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Methamphetamine, its salts, isomers, and salts of its isomers;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iii)(C)" name="58-37-4(2)(b)(iii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Phenmetrazine and its salts; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iii)(D)" name="58-37-4(2)(b)(iii)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Methylphenidate.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iv)" name="58-37-4(2)(b)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
<a id="58-37-4(2)(b)(iv)(A)" name="58-37-4(2)(b)(iv)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Amobarbital;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iv)(B)" name="58-37-4(2)(b)(iv)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Glutethimide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iv)(C)" name="58-37-4(2)(b)(iv)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Pentobarbital;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iv)(D)" name="58-37-4(2)(b)(iv)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Phencyclidine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iv)(E)" name="58-37-4(2)(b)(iv)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Phencyclidine immediate precursors: 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile (PCC); and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(iv)(F)" name="58-37-4(2)(b)(iv)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Secobarbital.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(v)" name="58-37-4(2)(b)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%"><a id="58-37-4(2)(b)(v)(A)" name="58-37-4(2)(b)(v)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of Phenylacetone.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(v)(B)" name="58-37-4(2)(b)(v)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Some of these substances may be known by trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(vi)" name="58-37-4(2)(b)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
Nabilone, another name for nabilone: (±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(b)(vii)" name="58-37-4(2)(b)(vii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vii)</td><td style="width:99%">
A drug product or preparation that contains any component of marijuana, including tetrahydrocannabinol, and is approved by the United States Food and Drug Administration and scheduled by the Drug Enforcement Administration in Schedule II of the federal Controlled Substances Act, Title II, P.L. 91-513.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)" name="58-37-4(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
Schedule III:<a id="58-37-4(2)(c)(i)" name="58-37-4(2)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers whether optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
<a id="58-37-4(2)(c)(i)(A)" name="58-37-4(2)(c)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(i)(B)" name="58-37-4(2)(c)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Benzphetamine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(i)(C)" name="58-37-4(2)(c)(i)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Chlorphentermine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(i)(D)" name="58-37-4(2)(c)(i)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Clortermine; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(i)(E)" name="58-37-4(2)(c)(i)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Phendimetrazine.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)" name="58-37-4(2)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
<a id="58-37-4(2)(c)(ii)(A)" name="58-37-4(2)(c)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients which are not listed in any schedule;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(B)" name="58-37-4(2)(c)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Any suppository dosage form containing amobarbital, secobarbital, or pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug Administration for marketing only as a suppository;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(C)" name="58-37-4(2)(c)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Any substance which contains any quantity of a derivative of barbituric acid or any salt of any of them;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(D)" name="58-37-4(2)(c)(ii)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Chlorhexadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(E)" name="58-37-4(2)(c)(ii)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Buprenorphine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(F)" name="58-37-4(2)(c)(ii)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under the federal Food, Drug, and Cosmetic Act, Section 505;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(G)" name="58-37-4(2)(c)(ii)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine: ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(H)" name="58-37-4(2)(c)(ii)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Lysergic acid;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(I)" name="58-37-4(2)(c)(ii)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Lysergic acid amide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(J)" name="58-37-4(2)(c)(ii)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Methyprylon;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(K)" name="58-37-4(2)(c)(ii)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Sulfondiethylmethane;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(L)" name="58-37-4(2)(c)(ii)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
Sulfonethylmethane;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(M)" name="58-37-4(2)(c)(ii)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
Sulfonmethane; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ii)(N)" name="58-37-4(2)(c)(ii)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Tiletamine and zolazepam or any of their salts, some trade or other names for a tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one, flupyrazapon.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(iii)" name="58-37-4(2)(c)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product, some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or (-)-delta-9-(trans)-tetrahydrocannabinol.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(iv)" name="58-37-4(2)(c)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
Nalorphine.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)" name="58-37-4(2)(c)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
<a id="58-37-4(2)(c)(v)(A)" name="58-37-4(2)(c)(v)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(B)" name="58-37-4(2)(c)(v)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(C)" name="58-37-4(2)(c)(v)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(D)" name="58-37-4(2)(c)(v)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(E)" name="58-37-4(2)(c)(v)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(F)" name="58-37-4(2)(c)(v)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(G)" name="58-37-4(2)(c)(v)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(v)(H)" name="58-37-4(2)(c)(v)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)" name="58-37-4(2)(c)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, anabolic steroids including any of the following or any isomer, ester, salt, or derivative of the following that promotes muscle growth:
<a id="58-37-4(2)(c)(vi)(A)" name="58-37-4(2)(c)(vi)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Boldenone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(B)" name="58-37-4(2)(c)(vi)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Chlorotestosterone (4-chlortestosterone);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(C)" name="58-37-4(2)(c)(vi)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Clostebol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(D)" name="58-37-4(2)(c)(vi)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Dehydrochlormethyltestosterone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(E)" name="58-37-4(2)(c)(vi)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Dihydrotestosterone (4-dihydrotestosterone);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(F)" name="58-37-4(2)(c)(vi)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Drostanolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(G)" name="58-37-4(2)(c)(vi)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Ethylestrenol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(H)" name="58-37-4(2)(c)(vi)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Fluoxymesterone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(I)" name="58-37-4(2)(c)(vi)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Formebulone (formebolone);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(J)" name="58-37-4(2)(c)(vi)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Mesterolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(K)" name="58-37-4(2)(c)(vi)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Methandienone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(L)" name="58-37-4(2)(c)(vi)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
Methandranone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(M)" name="58-37-4(2)(c)(vi)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
Methandriol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(N)" name="58-37-4(2)(c)(vi)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Methandrostenolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(O)" name="58-37-4(2)(c)(vi)(O)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(O)</td><td style="width:99%">
Methenolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(P)" name="58-37-4(2)(c)(vi)(P)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(P)</td><td style="width:99%">
Methyltestosterone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(Q)" name="58-37-4(2)(c)(vi)(Q)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Q)</td><td style="width:99%">
Mibolerone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(R)" name="58-37-4(2)(c)(vi)(R)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(R)</td><td style="width:99%">
Nandrolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(S)" name="58-37-4(2)(c)(vi)(S)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(S)</td><td style="width:99%">
Norethandrolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(T)" name="58-37-4(2)(c)(vi)(T)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(T)</td><td style="width:99%">
Oxandrolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(U)" name="58-37-4(2)(c)(vi)(U)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(U)</td><td style="width:99%">
Oxymesterone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(V)" name="58-37-4(2)(c)(vi)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Oxymetholone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(W)" name="58-37-4(2)(c)(vi)(W)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(W)</td><td style="width:99%">
Stanolone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(X)" name="58-37-4(2)(c)(vi)(X)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(X)</td><td style="width:99%">
Stanozolol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(Y)" name="58-37-4(2)(c)(vi)(Y)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Y)</td><td style="width:99%">
Testolactone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(Z)" name="58-37-4(2)(c)(vi)(Z)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Z)</td><td style="width:99%">
Testosterone; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vi)(AA)" name="58-37-4(2)(c)(vi)(AA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AA)</td><td style="width:99%">
Trenbolone.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(vii)" name="58-37-4(2)(c)(vii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vii)</td><td style="width:99%">
Anabolic steroids expressly intended for administration through implants to cattle or other nonhuman species, and approved by the Secretary of Health and Human Services for use, may not be classified as a controlled substance.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(viii)" name="58-37-4(2)(c)(viii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(viii)</td><td style="width:99%">
A drug product or preparation that contains any component of marijuana, including tetrahydrocannabinol, and is approved by the United States Food and Drug Administration and scheduled by the Drug Enforcement Administration in Schedule III of the federal Controlled Substances Act, Title II, P.L. 91-513.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(c)(ix)" name="58-37-4(2)(c)(ix)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ix)</td><td style="width:99%">
Nabiximols.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)" name="58-37-4(2)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
Schedule IV:<a id="58-37-4(2)(d)(i)" name="58-37-4(2)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)" name="58-37-4(2)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
<a id="58-37-4(2)(d)(ii)(A)" name="58-37-4(2)(d)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Alprazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(B)" name="58-37-4(2)(d)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Barbital;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(C)" name="58-37-4(2)(d)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Bromazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(D)" name="58-37-4(2)(d)(ii)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Butorphanol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(E)" name="58-37-4(2)(d)(ii)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Camazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(F)" name="58-37-4(2)(d)(ii)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Carisoprodol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(G)" name="58-37-4(2)(d)(ii)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Chloral betaine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(H)" name="58-37-4(2)(d)(ii)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Chloral hydrate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(I)" name="58-37-4(2)(d)(ii)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Chlordiazepoxide;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(J)" name="58-37-4(2)(d)(ii)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Clobazam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(K)" name="58-37-4(2)(d)(ii)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Clonazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(L)" name="58-37-4(2)(d)(ii)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
Clorazepate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(M)" name="58-37-4(2)(d)(ii)(M)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(M)</td><td style="width:99%">
Clotiazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(N)" name="58-37-4(2)(d)(ii)(N)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(N)</td><td style="width:99%">
Cloxazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(O)" name="58-37-4(2)(d)(ii)(O)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(O)</td><td style="width:99%">
Delorazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(P)" name="58-37-4(2)(d)(ii)(P)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(P)</td><td style="width:99%">
Diazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(Q)" name="58-37-4(2)(d)(ii)(Q)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Q)</td><td style="width:99%">
Dichloralphenazone;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(R)" name="58-37-4(2)(d)(ii)(R)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(R)</td><td style="width:99%">
Estazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(S)" name="58-37-4(2)(d)(ii)(S)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(S)</td><td style="width:99%">
Ethchlorvynol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(T)" name="58-37-4(2)(d)(ii)(T)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(T)</td><td style="width:99%">
Ethinamate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(U)" name="58-37-4(2)(d)(ii)(U)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(U)</td><td style="width:99%">
Ethyl loflazepate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(V)" name="58-37-4(2)(d)(ii)(V)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(V)</td><td style="width:99%">
Fludiazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(W)" name="58-37-4(2)(d)(ii)(W)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(W)</td><td style="width:99%">
Flunitrazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(X)" name="58-37-4(2)(d)(ii)(X)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(X)</td><td style="width:99%">
Flurazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(Y)" name="58-37-4(2)(d)(ii)(Y)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Y)</td><td style="width:99%">
Halazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(Z)" name="58-37-4(2)(d)(ii)(Z)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(Z)</td><td style="width:99%">
Haloxazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(AA)" name="58-37-4(2)(d)(ii)(AA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AA)</td><td style="width:99%">
Ketazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(BB)" name="58-37-4(2)(d)(ii)(BB)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(BB)</td><td style="width:99%">
Loprazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(CC)" name="58-37-4(2)(d)(ii)(CC)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(CC)</td><td style="width:99%">
Lorazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(DD)" name="58-37-4(2)(d)(ii)(DD)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(DD)</td><td style="width:99%">
Lormetazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(EE)" name="58-37-4(2)(d)(ii)(EE)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(EE)</td><td style="width:99%">
Mebutamate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(FF)" name="58-37-4(2)(d)(ii)(FF)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(FF)</td><td style="width:99%">
Medazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(GG)" name="58-37-4(2)(d)(ii)(GG)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(GG)</td><td style="width:99%">
Meprobamate;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(HH)" name="58-37-4(2)(d)(ii)(HH)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(HH)</td><td style="width:99%">
Methohexital;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(II)" name="58-37-4(2)(d)(ii)(II)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(II)</td><td style="width:99%">
Methylphenobarbital (mephobarbital);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(JJ)" name="58-37-4(2)(d)(ii)(JJ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(JJ)</td><td style="width:99%">
Midazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(KK)" name="58-37-4(2)(d)(ii)(KK)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(KK)</td><td style="width:99%">
Nimetazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(LL)" name="58-37-4(2)(d)(ii)(LL)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(LL)</td><td style="width:99%">
Nitrazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(MM)" name="58-37-4(2)(d)(ii)(MM)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(MM)</td><td style="width:99%">
Nordiazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(NN)" name="58-37-4(2)(d)(ii)(NN)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(NN)</td><td style="width:99%">
Oxazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(OO)" name="58-37-4(2)(d)(ii)(OO)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(OO)</td><td style="width:99%">
Oxazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(PP)" name="58-37-4(2)(d)(ii)(PP)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(PP)</td><td style="width:99%">
Paraldehyde;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(QQ)" name="58-37-4(2)(d)(ii)(QQ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(QQ)</td><td style="width:99%">
Pentazocine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(RR)" name="58-37-4(2)(d)(ii)(RR)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(RR)</td><td style="width:99%">
Petrichloral;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(SS)" name="58-37-4(2)(d)(ii)(SS)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(SS)</td><td style="width:99%">
Phenobarbital;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(TT)" name="58-37-4(2)(d)(ii)(TT)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(TT)</td><td style="width:99%">
Pinazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(UU)" name="58-37-4(2)(d)(ii)(UU)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(UU)</td><td style="width:99%">
Prazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(VV)" name="58-37-4(2)(d)(ii)(VV)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(VV)</td><td style="width:99%">
Quazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(WW)" name="58-37-4(2)(d)(ii)(WW)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(WW)</td><td style="width:99%">
Temazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(XX)" name="58-37-4(2)(d)(ii)(XX)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(XX)</td><td style="width:99%">
Tetrazepam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(YY)" name="58-37-4(2)(d)(ii)(YY)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(YY)</td><td style="width:99%">
Tramadol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(ZZ)" name="58-37-4(2)(d)(ii)(ZZ)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ZZ)</td><td style="width:99%">
Triazolam;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(AAA)" name="58-37-4(2)(d)(ii)(AAA)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(AAA)</td><td style="width:99%">
Zaleplon; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(ii)(BBB)" name="58-37-4(2)(d)(ii)(BBB)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(BBB)</td><td style="width:99%">
Zolpidem.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iii)" name="58-37-4(2)(d)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
Any material, compound, mixture, or preparation of fenfluramine which contains any quantity of the following substances, including its salts, isomers whether optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)" name="58-37-4(2)(d)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers whether optical, position, or geometric isomers, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
<a id="58-37-4(2)(d)(iv)(A)" name="58-37-4(2)(d)(iv)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
Cathine ((+)-norpseudoephedrine);</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(B)" name="58-37-4(2)(d)(iv)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
Diethylpropion;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(C)" name="58-37-4(2)(d)(iv)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
Fencamfamine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(D)" name="58-37-4(2)(d)(iv)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
Fenproprex;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(E)" name="58-37-4(2)(d)(iv)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
Mazindol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(F)" name="58-37-4(2)(d)(iv)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
Mefenorex;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(G)" name="58-37-4(2)(d)(iv)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
Modafinil;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(H)" name="58-37-4(2)(d)(iv)(H)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(H)</td><td style="width:99%">
Pemoline, including organometallic complexes and chelates thereof;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(I)" name="58-37-4(2)(d)(iv)(I)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(I)</td><td style="width:99%">
Phentermine;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(J)" name="58-37-4(2)(d)(iv)(J)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(J)</td><td style="width:99%">
Pipradrol;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(K)" name="58-37-4(2)(d)(iv)(K)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(K)</td><td style="width:99%">
Sibutramine; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(iv)(L)" name="58-37-4(2)(d)(iv)(L)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(L)</td><td style="width:99%">
SPA ((-)-1-dimethylamino-1,2-diphenylethane).</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(v)" name="58-37-4(2)(d)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(d)(vi)" name="58-37-4(2)(d)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
A drug product or preparation that contains any component of marijuana and is approved by the United States Food and Drug Administration and scheduled by the Drug Enforcement Administration in Schedule IV of the federal Controlled Substances Act, Title II, P.L. 91-513.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)" name="58-37-4(2)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
Schedule V:<a id="58-37-4(2)(e)(i)" name="58-37-4(2)(e)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
<a id="58-37-4(2)(e)(i)(A)" name="58-37-4(2)(e)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(i)(B)" name="58-37-4(2)(e)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(i)(C)" name="58-37-4(2)(e)(i)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(i)(D)" name="58-37-4(2)(e)(i)(D)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(D)</td><td style="width:99%">
not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(i)(E)" name="58-37-4(2)(e)(i)(E)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(E)</td><td style="width:99%">
not more than 100 milligrams of opium per 100 milliliters or per 100 grams;</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(i)(F)" name="58-37-4(2)(e)(i)(F)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(F)</td><td style="width:99%">
not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit; and</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(i)(G)" name="58-37-4(2)(e)(i)(G)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(G)</td><td style="width:99%">
unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-4(2)(e)(ii)" name="58-37-4(2)(e)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
A drug product or preparation that contains any component of marijuana, including cannabidiol, and is approved by the United States Food and Drug Administration and scheduled by the Drug Enforcement Administration in Schedule V of the federal Controlled Substances Act, Title II, P.L. 91-513. </td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=165&amp;sess=2022GS">165</a>, 2022 General Session<br>
</body></html>